Randy To Talk February 19th In New York City - 2013 STEM CELL SUMMIT
Disrupting the Pharma Model with Allogeneic Stem Cell Therapies
The Pharma model may be broken. Can allogeneic stem cell therapies save it?
Traditional drug development means screening 10,000 compounds to get to 250 animal study candidates to get to 10 human study candidates to market 2 drugs. It takes so long that patents expire and costs can reach $500 million. Could stem cell therapies turn the Pharma model on its head?